![]() ![]() On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis. Keywords: End-Stage Liver Disease Outcome. Conclusion: MELD 3.0 affords more accurate mortality prediction in general than MELDNa and addresses determinants of wait list outcomes, including the sex disparity. Yip TC, Chan HL, Tse YK, Lam KL, Lui GC, Wong VW, et al. In the Liver Simulated Allocation Model analysis, MELD 3.0 resulted in fewer wait list deaths compared to MELDNa (7788 vs 7850 P. University of Wisconsin School of Medicine and Public Health. Model for End-stage Liver Disease (MELD) score and liver transplant: benefits and concerns. doi:10.2147/CEG.S160537Īiello FI, Bajo M, Marti F, Gadano A, Musso CG. The MELD score (Model for End-Stage Liver Disease) is used to estimate prognosis in patients with liver failure. Liver function tests in identifying patients with liver disease. Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values. Johnson SA, Vazquez SR, Fleming R, Lanspa MJ. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study. ![]() The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. Zaydfudim VM, Turrentine FE, Smolkin ME, et al. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. Important predictor of mortality in patients with end-stage liver disease. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |